142 related articles for article (PubMed ID: 30954430)
1. Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and/or colistin resistant Enterobacteriaceae isolates.
Xu J; Pachón-Ibáñez ME; Cebrero-Cangueiro T; Chen H; Sánchez-Céspedes J; Zhou J
Bioorg Med Chem Lett; 2019 Jun; 29(11):1399-1402. PubMed ID: 30954430
[TBL] [Abstract][Full Text] [Related]
2.
Cebrero-Cangueiro T; Álvarez-Marín R; Labrador-Herrera G; Smani Y; Cordero-Matía E; Pachón J; Pachón-Ibáñez ME
Front Cell Infect Microbiol; 2018; 8():363. PubMed ID: 30406040
[TBL] [Abstract][Full Text] [Related]
3. High rate of colistin and fosfomycin resistance among carbapenemase-producing Enterobacteriaceae in Turkey.
Süzük Yıldız S; Kaşkatepe B; Şimşek H; Sarıgüzel FM
Acta Microbiol Immunol Hung; 2019 Mar; 66(1):103-112. PubMed ID: 30403361
[TBL] [Abstract][Full Text] [Related]
4. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
Bradford PA; Kazmierczak KM; Biedenbach DJ; Wise MG; Hackel M; Sahm DF
Antimicrob Agents Chemother; 2015 Dec; 60(3):1385-92. PubMed ID: 26666920
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activities of imipenem-colistin, imipenem-tigecycline, and tigecycline-colistin combinations against carbapenem-resistant Enterobacteriaceae.
Dundar D; Duymaz Z; Genc S; Er DK; İrvem A; Kandemir N
J Chemother; 2018; 30(6-8):342-347. PubMed ID: 30663555
[TBL] [Abstract][Full Text] [Related]
6. Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant
Jangra M; Kaur M; Tambat R; Rana R; Maurya SK; Khatri N; Ghafur A; Nandanwar H
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936101
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.
Brennan-Krohn T; Pironti A; Kirby JE
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061285
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
9.
Teo JWP; Kalisvar M; Venkatachalam I; Ng OT; Lin RTP; Octavia S
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237785
[No Abstract] [Full Text] [Related]
10. In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE.
Okanda T; Matsumoto T
J Infect Chemother; 2020 Apr; 26(4):322-330. PubMed ID: 31924522
[TBL] [Abstract][Full Text] [Related]
11. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
13. Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam Resistance.
Shields RK; Nguyen MH; Hao B; Kline EG; Clancy CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891598
[TBL] [Abstract][Full Text] [Related]
14. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á
Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587
[TBL] [Abstract][Full Text] [Related]
15. Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital.
Ferranti M; Schiaroli E; Palmieri MI; Repetto A; Vecchiarelli A; Francisci D; Mencacci A; Monari C
New Microbiol; 2018 Oct; 41(4):274-281. PubMed ID: 30252925
[TBL] [Abstract][Full Text] [Related]
16. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
Crémieux AC; Dinh A; Nordmann P; Mouton W; Tattevin P; Ghout I; Jayol A; Aimer O; Gatin L; Verdier MC; Saleh-Mghir A; Laurent F
J Antimicrob Chemother; 2019 Sep; 74(9):2666-2675. PubMed ID: 31263884
[TBL] [Abstract][Full Text] [Related]
18. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
[TBL] [Abstract][Full Text] [Related]
19. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
[TBL] [Abstract][Full Text] [Related]
20. Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.
Koren J; Hubenakova Z; Drahovska H; Ozaee E; Markuskova B; Lichvarikova A
Bratisl Lek Listy; 2019; 120(12):935-940. PubMed ID: 31855054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]